Clinical Trial Update: Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating HB-1 for post-traumatic stress disorder is not yet recruiting, focusing on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• HB-1

Snippet

Sponsor: HB BioTech, LLC | Conditions: PTSD, Mental Illness | Phase 2 | Status: NOT_YET_RECRUITING